Dr. Liz Kwo has 20+ years of experience in building digital health and medical management companies, with a focus on using data analytics to transform health and wellness at scale. Currently she is the Chief Medical Officer of Everly Health, the digital health company at the forefront of the $300 billion virtual diagnostics-driven care industry, with an aim to provide consumers access to at-home lab tests that include insightful, easy-to-understand results. Most recently, Dr. Kwo served as Deputy Chief Clinical Officer for Elevance (NYSE: ELV) to modernize disease management and care delivery for 43 million Americans covered under Medicare, Medicaid, and Commercial businesses. Prior to Elevance, Dr. Kwo started several venture backed companies as the CEO and co-founder of InfiniteMD (acquired by Consumer Medical, subsequently acquired by Alight (NYSE: ALIT) and President and co-founder of New Pathway Education and Technology Group (acquired by EIC Education). Her prior healthcare work includes supporting clinical data innovation at American Well (NYSE: AMWL), Medtronic (NYSE: MDT), and Third Rock.
Dr. Kwo is on the Board of Directors of Asensus (NYSE AMERICAN: ASXC), Walmart Mexico and Central America (Mexican Stock Exchange/BMV: WALMEX), BlueWind Medical and ChroniSense. Dr. Kwo continues to see patients in urgent care at Cambridge Health Alliance Hospital, teach residents as a faculty lecturer at Harvard Medical School, and is board certified in Preventive Care and Occupational Medicine. She earned a BA in Human Biology from Stanford University, MD from Harvard Medical School, MBA from Harvard Business School, and an MPH from Harvard T.H. Chan School of Public Health.